TITLE:
A Single Dose of a Marketed Drug Being Studied for a New Indication to Treat Surgical Site Infection Following Colorectal Surgery as Compared to a Marketed Drug Approved for This Indication (0826-039)

CONDITION:
Colorectal Surgery

INTERVENTION:
MK0826, ertapenem sodium

SUMMARY:

      The objective of this study is to evaluate the safety and efficacy of a one time dose of an
      intravenous marketed drug being evaluated for a new indication as compared to a marketed
      drug already approved for the prevention of surgical site infection following colorectal
      surgery.
    

DETAILED DESCRIPTION:

      The duration of treatment is 1 day.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

        Male or female patients 18 years of age scheduled to undergo elective colon or colorectal
        surgery by laparotomy must meet the following criteria:

          -  Surgery must be scheduled in advance.

          -  There must be adequate time to complete preoperative bowel preparation
      
